Boston Common Asset Management, LLC Novartis Ag Transaction History

Boston Common Asset Management, LLC

  • $3.84 Billion
  • Q3 2024

A detailed history of Boston Common Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 166,173 shares of NVS stock, worth $16.1 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
166,173
Previous 160,804 3.34%
Holding current value
$16.1 Million
Previous $17.1 Million 11.65%
% of portfolio
0.5%
Previous 0.44%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024
BUY
$106.13 - $120.89 $569,811 - $649,058
5,369 Added 3.34%
166,173 $19.1 Million
Q2 2024

Jul 08, 2024
SELL
$92.57 - $107.37 $9,257 - $10,737
-100 Reduced 0.06%
160,804 $17.1 Million
Q1 2024

Apr 11, 2024
SELL
$95.27 - $108.47 $1.2 Million - $1.37 Million
-12,641 Reduced 7.28%
160,904 $15.6 Million
Q4 2023

Jan 09, 2024
SELL
$92.27 - $101.54 $1.29 Million - $1.41 Million
-13,927 Reduced 7.43%
173,545 $17.5 Million
Q3 2023

Oct 11, 2023
SELL
$94.73 - $105.13 $539,582 - $598,820
-5,696 Reduced 2.95%
187,472 $19.1 Million
Q2 2023

Jul 24, 2023
SELL
$92.52 - $104.91 $94,370 - $107,008
-1,020 Reduced 0.53%
193,168 $19.5 Million
Q1 2023

May 17, 2023
SELL
$80.03 - $92.81 $4.87 Million - $5.65 Million
-60,851 Reduced 23.86%
194,188 $17.9 Million
Q4 2022

Jan 26, 2023
SELL
$75.55 - $92.52 $1.43 Million - $1.75 Million
-18,949 Reduced 6.92%
255,039 $23.1 Million
Q3 2022

Oct 20, 2022
SELL
$74.61 - $87.26 $403,490 - $471,902
-5,408 Reduced 1.94%
273,988 $20.8 Million
Q2 2022

Aug 10, 2022
BUY
$80.52 - $93.75 $3.72 Million - $4.33 Million
46,180 Added 19.8%
279,396 $23.6 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $4.27 Million - $4.83 Million
53,293 Added 29.62%
233,216 $20.5 Million
Q4 2021

Jan 31, 2022
BUY
$79.7 - $88.13 $385,190 - $425,932
4,833 Added 2.76%
179,923 $15.7 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $743,053 - $864,442
9,086 Added 5.47%
175,090 $14.3 Million
Q2 2021

Aug 19, 2021
BUY
$85.24 - $94.15 $739,286 - $816,562
8,673 Added 5.51%
166,004 $15.1 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $851,700 - $1 Million
10,200 Added 6.93%
157,331 $13.4 Million
Q4 2020

Feb 05, 2021
BUY
$78.07 - $94.43 $247,559 - $299,437
3,171 Added 2.2%
147,131 $13.9 Million
Q3 2020

Nov 10, 2020
SELL
$82.14 - $91.0 $1.53 Million - $1.69 Million
-18,581 Reduced 11.43%
143,960 $12.5 Million
Q2 2020

Aug 10, 2020
BUY
$80.93 - $91.1 $53,251 - $59,943
658 Added 0.41%
162,541 $14.2 Million
Q1 2020

May 08, 2020
BUY
$70.67 - $99.01 $408,472 - $572,277
5,780 Added 3.7%
161,883 $13.3 Million
Q4 2019

Jan 28, 2020
BUY
$84.35 - $95.37 $9,700 - $10,967
115 Added 0.07%
156,103 $14.8 Million
Q3 2019

Nov 07, 2019
SELL
$85.54 - $94.26 $1.14 Million - $1.26 Million
-13,326 Reduced 7.87%
155,988 $13.6 Million
Q2 2019

Jul 26, 2019
SELL
$75.4 - $92.8 $1.76 Million - $2.16 Million
-23,282 Reduced 12.09%
169,314 $15.5 Million
Q1 2019

May 03, 2019
SELL
$75.32 - $86.15 $4,669 - $5,341
-62 Reduced 0.03%
192,596 $18.5 Million
Q4 2018

Jan 25, 2019
BUY
$73.66 - $82.02 $2.56 Million - $2.85 Million
34,698 Added 21.97%
192,658 $16.5 Million
Q3 2018

Nov 01, 2018
SELL
$66.94 - $77.43 $66,940 - $77,430
-1,000 Reduced 0.63%
157,960 $13.6 Million
Q2 2018

Aug 06, 2018
BUY
$64.91 - $73.36 $1.14 Million - $1.29 Million
17,577 Added 12.43%
158,960 $12 Million
Q1 2018

Apr 26, 2018
BUY
$70.39 - $84.15 $552,843 - $660,914
7,854 Added 5.88%
141,383 $11.4 Million
Q4 2017

Feb 07, 2018
SELL
$72.33 - $77.64 $11,862 - $12,732
-164 Reduced 0.12%
133,529 $11.2 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $161,995 - $168,834
2,185 Added 1.66%
133,693 $11.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
131,508
131,508 $11 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Boston Common Asset Management, LLC Portfolio

Follow Boston Common Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email